An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for drug overdose medication.

SB 1022 amends Pennsylvania's Controlled Substance Act to clarify definitions related to drug overdose medication. It specifically defines terms for medications like naloxone used to reverse overdoses, ensuring healthcare providers and pharmacists have clear legal guidance. The bill directly affects medical professionals who administer or distribute overdose reversal treatments. This procedural amendment updates existing law without creating new programs or funding.